News from NORD

Running Marathons to Advance Rare Disease Awareness and Diagnosis


 

Running for Rare, NORD’s signature charity marathon team, participated as an official charity partner in the Tata Consultancy Services (TCS) New York City Marathon in November. The team participates in several marathons and half-marathons each year to raise funds for NORD’s program for undiagnosed patients. Specifically, the NORD program provides financial assistance for medical testing required of applicants to the Undiagnosed Diseases Network (UDN).

Each runner on the team is paired with a rare disease patient partner. Runners and their partners provide inspiration to each other and promote awareness of specific rare diseases. They also raise funds for the NORD Patient Assistance Program, to which undiagnosed patients are referred by staff at clinical centers affiliated with the UDN.

The team has planned an ambitious season for 2017 beginning with the Los Angeles Marathon on March 19. Runners interested in joining the team can learn more on the NORD website .

Recommended Reading

Hemophilia drugs top Medicaid spending per prescription
MDedge Pediatrics
Children under 6 with factor XIII deficiency had no major bleeds with recombinant product
MDedge Pediatrics
Study evaluates Zika syndrome with joint contractures
MDedge Pediatrics
SHARE initiative releases consensus-based JDM management recommendations
MDedge Pediatrics
CANDLE syndrome case highlights key features of this type 1 interferonopathy
MDedge Pediatrics
Case-control study points to Zika virus as cause of microcephaly
MDedge Pediatrics
FDA approves Duchenne muscular dystrophy treatment under ‘accelerated pathway’
MDedge Pediatrics
Congenital Zika syndrome includes range of neurologic abnormalities
MDedge Pediatrics
NORD Urges Congress to Pass 21st Century Cures Act
MDedge Pediatrics
Nominate a Colleague for a NORD 2017 Rare Impact Award
MDedge Pediatrics